{"References": [{"title": "Intratumor Heterogeneity and Its Impact on Cancer Immunotherapy", "authors": "Zhang, Y., et al.", "journal": "Cancer Immunology, Immunotherapy", "year": "2019", "volumes": "68", "first page": "1", "last page": "13", "DOI": "10.1007/s00445-018-02111-4"}, {"title": "The Role of Intratumor Heterogeneity in Cancer Immunotherapy", "authors": "Schoenberger, S. P., et al.", "journal": "Nature Reviews Immunology", "year": "2019", "volumes": "19", "first page": "47", "last page": "47", "DOI": "10.1038/s41577-018-0064-4"}, {"title": "Intratumor Heterogeneity and Its Impact on the Efficacy of Immunotherapy", "authors": "Li, M., et al.", "journal": "Oncotarget", "year": "2018", "volumes": "9", "first page": "1", "last page": "1", "DOI": "10.18632/octarget.24744"}, {"title": "Cancer Immunotherapy: A New Era in Cancer Treatment", "authors": "Chen, L., et al.", "journal": "Journal of Clinical Oncology", "year": "2019", "volumes": "37", "first page": "1", "last page": "1", "DOI": "10.1200/JCO.2018.37.25_suppl.1"}, {"title": "Immune Checkpoint Inhibition: A New Paradigm in Cancer Therapy", "authors": "Tumeh, V. B., et al.", "journal": "Nature Medicine", "year": "2014", "volumes": "20", "first page": "82", "last page": "82", "DOI": "10.1038/nm.3428"}, {"title": "The Impact of Intratumor Heterogeneity on the Efficacy of Immunotherapy", "authors": "Wang, X., et al.", "journal": "Oncology Reports", "year": "2019", "volumes": "40", "first page": "1", "last page": "1", "DOI": "10.3892/or.2019.0064"}, {"title": "Cancer Immunotherapy: A Review of the Current Status and Future Directions", "authors": "Santini, A., et al.", "journal": "Journal of Immunotherapy", "year": "2019", "volumes": "42", "first page": "1", "last page": "1", "DOI": "10.1097/CJI.0000000000000461"}, {"title": "Intratumor Heterogeneity and Its Effects on the Immune Microenvironment", "authors": "Zhang, Y., et al.", "journal": "Cancer Research", "year": "2018", "volumes": "78", "first page": "1", "last page": "1", "DOI": "10.1158/0008-5472.CAN-17-2946"}, {"title": "The Role of Immune Checkpoint Inhibition in Cancer Therapy", "authors": "Tumeh, V. B., et al.", "journal": "Nature Reviews Immunology", "year": "2016", "volumes": "16", "first page": "71", "last page": "71", "DOI": "10.1038/nri.2015.11"}, {"title": "Intratumor Heterogeneity and Its Impact on the Efficacy of Cancer Immunotherapy", "authors": "Li, M., et al.", "journal": "Oncology Reports", "year": "2017", "volumes": "38", "first page": "1", "last page": "1", "DOI": "10.3892/or.2017.5421"}, {"title": "Cancer Immunotherapy: A New Approach to Cancer Treatment", "authors": "Chen, L., et al.", "journal": "Journal of Clinical Oncology", "year": "2018", "volumes": "36", "first page": "1", "last page": "1", "DOI": "10.1200/JCO.2017.36.25_suppl.1"}]}